4.37

1.63% 0.07

After Hours: 4.29 -0.08 -1.83%

Cytek Biosciences Inc (CTKB)

Overview News Price History Option Chain Financials Discussions Forecast

Cytek Biosciences Inc stock is traded at $4.37, with a volume of 584.11K. It is up +1.63% in the last 24 hours and down -2.46% over the past month. Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

Previous Close:

$4.30

Open:

$4.34

24h Volume:

584.11K

Relative Volume:

0.72

Market Cap:

$561.76M

Revenue:

$201.49M

Net Income/Loss:

$-66.54M

P/E Ratio:

-8.4087

EPS:

-0.5197

Net Cash Flow:

$-8.88M

1W Performance:

-5.62%

1M Performance:

-2.46%

6M Performance:

+25.94%

1Y Performance:

+8.98%

1-Day Range:

$4.335

$4.485

1-Week Range:

$4.19

$4.745

52-Week Range:

$2.37

$6.18

Cytek Biosciences Inc Stock (CTKB) Company Profile

Name

Cytek Biosciences Inc

Sector

Healthcare (1114)

Industry

Medical Devices (143)

Phone

(877) 922-9835

Address

47215 LAKEVIEW BOULEVARD, FREMONT

Employee

702

Twitter

Next Earnings Date

2024-11-05

Latest SEC Filings

CTKB's Discussions on Twitter

Compare CTKB vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CTKB Cytek Biosciences Inc	4.37	552.77M	201.49M	-66.54M	-8.88M	-0.5197
ABT Abbott Laboratories	102.67	177.03B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	328.59	124.89B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	86.65	110.08B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	62.75	93.53B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	80.08	45.84B	6.07B	1.06B	1.34B	1.8063

Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-02-25	Resumed	Morgan Stanley	Equal-Weight
May-09-25	Downgrade	TD Cowen	Buy → Hold
Jan-31-25	Downgrade	Goldman	Buy → Sell
Dec-14-23	Initiated	Stephens	Overweight
Jul-19-23	Initiated	Raymond James	Mkt Perform
Jan-06-22	Resumed	Piper Sandler	Overweight

View All

Cytek Biosciences Inc Stock (CTKB) Latest News

07:39 AM

Tudor Investment Corp ET AL Invests $867,000 in Cytek Biosciences, Inc. $CTKB - MarketBeat

07:39 AM

Mar 30, 2026

Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives $5.38 Consensus PT from Analysts - Defense World

Mar 30, 2026

Mar 27, 2026

Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Mar 27, 2026

Mar 26, 2026

Vanguard realignment leaves Cytek (NASDAQ: CTKB) ownership at 0 after amendment - Stock Titan

Mar 26, 2026

Nautilus Biotechnology And 2 Other Compelling Penny Stocks For Your Watchlist - Sahm

Mar 26, 2026

Mar 25, 2026

EPS Watch: What is the Moat Score of Cytek Biosciences Inc2026 Rallies & Smart Allocation Stock Reports - baoquankhu1.vn

Mar 25, 2026

Mar 23, 2026

Cytek Biosciences outlines $205M–$212M 2026 revenue target amid record Q4 and growth in recurring revenue - MSN

Mar 23, 2026

Mar 18, 2026

Tranche Update on Cytek Biosciences, Inc.'s Equity Buyback Plan announced on December 30, 2024. - marketscreener.com

Mar 18, 2026

Mar 17, 2026

CTKB Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Mar 17, 2026

Mar 15, 2026

Cytek Biosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Mar 15, 2026

Mar 14, 2026

Topline Capital Management LLC Has $24.10 Million Position in Cytek Biosciences, Inc. $CTKB - MarketBeat

Mar 14, 2026

Mar 12, 2026

US Stocks Recap: How does Cytek Biosciences Inc compare to its peersMarket Growth Report & Real-Time Market Sentiment Reports - baoquankhu1.vn

Mar 12, 2026

Cytek Biosciences (CTKB) director converts 6,107 RSUs into common stock - Stock Titan

Mar 12, 2026

Cytek Biosciences (CTKB) CLO receives new options, 226,453 RSUs and stock from vesting - Stock Titan

Mar 12, 2026

Cytek Biosciences (NASDAQ: CTKB) SVP granted options, RSUs and sees RSU vesting - Stock Titan

Mar 12, 2026

Cytek Biosciences (CTKB) CEO awarded options, RSUs and surrenders shares for taxes - Stock Titan

Mar 12, 2026

Cytek Biosciences (CTKB) CFO receives new equity awards and RSU vesting - Stock Titan

Mar 12, 2026

Cytek Biosciences (CTKB) CTO granted stock options and 227,535 RSUs - Stock Titan

Mar 12, 2026

Cytek Biosciences (NASDAQ: CTKB) director gains 2,908 shares via RSU vesting - Stock Titan

Mar 12, 2026

Latest CTKB NewsAmberstone Biosciences Secures $12 Million ... - Stock Titan

Mar 12, 2026

Mar 11, 2026

Sell Signal: What is the Moat Score of Cytek Biosciences IncTrade Performance Summary & AI Driven Stock Price Forecasts - baoquankhu1.vn

Mar 11, 2026

Mar 10, 2026

Cytek Biosciences expands global reach with one year of Singapore operations - Traders Union

Mar 10, 2026

Mar 09, 2026

Cytek Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact - Bitget

Mar 09, 2026

Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact - Weekly Voice

Mar 09, 2026

Cytek Biosciences Highlights Aurora Evo, Recurring Revenue Growth and 2026 Outlook at TD Cowen Conference - Yahoo Finance

Mar 09, 2026

Mar 08, 2026

How The Cytek Biosciences (CTKB) Story Is Shifting With New Targets And 2026 Guidance - Yahoo Finance

Mar 08, 2026

Mar 07, 2026

Cytek Biosciences Balances Growth With Margin Strain - The Globe and Mail

Mar 07, 2026

Mar 06, 2026